Jun 16, 2024, 14:05 | Blog

Farina Arreguin: Germline predisposition of genetic testing in myeloid malignancies

Farina Arreguin, a Pediatric Oncologist at Star Medical Private Children’s Hospital, shared a post on…

Jun 11, 2024, 12:10 | Blog

Michelle Kirschner: Sami Mansfield will speak about Exercise Oncology for the Cancer Survivorship Provider Network

Michelle Kirschner recently shared a post by Sami Mansfield, Founder of Cancer Wellness for Life,…

Jun 9, 2024, 07:57 | Positive

Lucia Masarova: The best leukemia ladies group in the world

Lucia Masarova, Assistant Professor at MD Anderson Cancer Centre, shared a post by Wei Ying…

May 31, 2024, 05:37 | Societies

A groundbreaking moment from 2017— the FDA approval of Kymriah - St. Baldrick's Foundation

St. Baldrick's Foundation shared a post on LinkedIn: “Today, we're looking back on a groundbreaking…

May 24, 2024, 13:11 | Blog

Kelley Wood: We observed significant improvements in Quality of Life across 12 different cancer types

Kelley Wood, Research Director at ReVital Cancer Rehab, made the following post on LinkedIn: “NEW PUB…

May 23, 2024, 09:19 | Blog

Stephen D. Nimer's recent study could lead to a new combination therapy for leukemia

Sylvester Comprehensive Cancer Center shared a post on X: “Stephen D. Nimer's recent study could lead…

May 22, 2024, 01:53 | Insight

Nitin Jain: Looking forward to presenting phase 2 trial of frontline treatment for patients with CLL at EHA 2024

Nitin Jain, Professor of the Department of Leukemia at MD Anderson Cancer Center, shared on…

May 18, 2024, 04:46 | Blog

Douglas Flora: Wonderful start to the day at The Leukemia and amp; Lymphoma Society’s Light The Night executive breakfast

Quoting Douglas Flora’s post on LinkedIn: “Had a wonderful start to the day at The Leukemia…

May 15, 2024, 14:47 | Drugs

Hagop Kantarjian: New research is expanding inotuzumab use into frontline, for MRD+, and in combination with blinatumomab

Nicholas Short, Associate Professor at the Department of Leukemia at MD Anderson Cancer Center, shared…

May 13, 2024, 13:11 | Insight

Justin Kaner: To transplant or not to transplant…..

Justin Kaner, Assistant Professor of the Leukemia Program at Weill Cornell, shared on X: "To…

May 10, 2024, 11:47 | Blog

Andrew M. Evens: Thank you for the invite to the 1st HemeOnc Pulse LIVE

Andrew M. Evens, Deputy Director for Clinical Services at Rutgers Cancer Institute, recently shared on…

May 5, 2024, 06:00 | Cancer Types

Acute Lymphoblastic Leukemia in Adults: What patients should know about

What is Acute Lymphoblastic Leukemia? Acute lymphoblastic leukemia (ALL) is a type of cancer that…

Apr 30, 2024, 16:14 | Stories

Pat Garcia-Gonzalez: Ethiopia Revisited - on the strength of the human spirit and progress in the face of adversity

Pat Garcia-Gonzalez, Chief Executive Officer at The Max Foundation, shared on LinkedIn: "Earlier last week,…

Apr 28, 2024, 13:08 | Blog

Celebrating 5-year anniversary of being cancer-free Jennifer’s daughter, Inara - Canadian Cancer Society

Canadian Cancer Society shared a post on LinkedIn: “In the winter of 2016, Jennifer’s daughter,…

Apr 25, 2024, 20:01 | Blog

Naveen Pemmaraju: Serious meeting of the heme minds today with Prof. Naveen Pemmaraju and Prof. Jason Westin

Naveen Pemmaraju shared on X: "Co-fellows to Co-Professors together at MD Anderson Cancer Center! Serious…

Apr 21, 2024, 09:04 | Blog

Naveen Pemmaraju: Brilliant talk Leukemia Wed noon Grand Rounds by Dr. Sanam Loghavi on new applications of Optical Genome Mapping (OGM) in AML!

Naveen Pemmaraju posted on X/Twitter: "Brilliant talk today MD Anderson Cancer Center Leukemia Wed noon…

Apr 20, 2024, 18:21 | Insight

Piotr Wysocki: Pregnancy and anticancer immunotherapy - How safe is accidental exposure to immune checkpoint inhibitors?

Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…

Apr 15, 2024, 02:40 | Insight

Naveen Pemmaraju: Check out our exciting growing international BPDCN collaboration with Dr. Gevorg Tamamyan and Armenia

Quoting Naveen Pemmaraju on X/Twitter: "Check out our exciting growing international BPDCN collaboration with Dr.…

Apr 9, 2024, 05:27 | Positive

George Yaghmour: Against the relentless battle of leukemia, success demands unwavering strength

George Yaghmour, Associate Director of USC Norris Blood and Marrow Transplant Program at University of Southern…

Apr 8, 2024, 21:58 | Blog,Insight

Katherine Masih: Super interesting work on activation of CAR-negative T-cells and subsequent cytotoxic killing of leukemia

Katherine Masih, Medical Student at University of Miami Miller School of Medicine, shared on X/Twitter:…

Apr 6, 2024, 12:48 | Positive

Naveen Pemmaraju: MD Anderson Cancer Center (MDACC) is a special place of hope and inspiration

Quoting Naveen Pemmaraju's post on LinkedIn: "When On Service: I am an Attending in the…

Apr 5, 2024, 16:47 | Positive

Naveen Pemmaraju: Awesome team to round with on Leukemia Inpatient wards this month

Naveen Pemmaraju recently posted on X: "Awesome team to round with on Leukemia Inpatient wards…

Mar 12, 2024, 15:53 | Blog

Naveen Pemmaraju: Congratulations to Kuo-Kai Chin for being awarded the Ruben Mesa Junior Clinical Investigator Award

Naveen Pemmaraju posted on X/Twitter: ''Congratulations to Kuo-Kai Chin for being awarded the Ruben Mesa…

Mar 9, 2024, 12:53 | Blog

Amer Zeidan: No leukemia cell would stand a chance against this group

Amer Zeidan recently posted on X/Twitter: "No leukemia cell would stand a chance against this group."…

Mar 2, 2024, 19:00 | Opinion

Richard Shadyac: How many of us can say without a doubt, “I know why I was born.”?

Shannon Goldberg-Cruz, Head of Entertainment and Influence at St. Jude Children's Research Hospital, shared a…

Feb 21, 2024, 20:45 | Blog

Peter Pisters: Delighted to drop by MD Anderson Cancer Center's Leukemia faculty to discuss the exceptional breakthroughs over the years

Peter Pisters, President at MD Anderson Cancer Center, shared on LinkedIn: “Delighted to drop by…

Jan 25, 2024, 13:45 | Blog

Satya Prakash Yadav: Bone marrow transplant is life-changing event for children

Satya Prakash Yadav, Paediatric Hemato Oncology and Bone Marrow Transplant Specialist at Medanta The Medicity,…

Jan 23, 2024, 18:10 | Insight

Manasi Gupta: What an exceptional learning experience!

Prashant Mehta, Joint Editor of Indian Journal of Medical and Paediatric Oncology, shared an X…

Jan 10, 2024, 12:42 | Blog

Danielle Hammond: Proof of concept and breaks the yoke of the infusion center

Danielle Hammond, Assistant Professor at the Department of Leukemia at MD Anderson Cancer Center, shared…

Jan 9, 2024, 13:10 | Blog

Hagop Kantarjian: Updates on the management of Ph-positive ALL

Hagop Kantarjian, Chair of MD Anderson Cancer Center, shared on X/Twitter: “Updates on the management…

Dec 23, 2023, 17:05 | Blog

Hagop Kantarjian: Traditional Medicare or Medicare Advantage?

Hagop Kantarjian, Chair of MD Anderson Cancer Center, shared on X/Twitter: "Traditional Medicare or Medicare…

Dec 18, 2023, 21:10 | Career

Congratulations to Dr. Ross Levine who was honored by the The Leukemia and Lymphoma Society - Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center shared on LinkedIn: "Congratulations to leukemia specialist and physician-scientist Dr.…

Dec 16, 2023, 16:32 | Blog

Keith Pratz: Mentors can influence greatly your career

Keith Pratz, Associate Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania,…

Dec 11, 2023, 11:01 | Stories

Danielle Carnival: You’re never too young to make a difference!

Danielle Carnival, Deputy Assistant to President Biden for the Cancer Moonshot, posted on X/Twitter: "The…

Dec 2, 2023, 17:33 | Career

Leukaemia and Myeloma Research UK awarded grants to Neil Rodrigues and Concetta Bubici

Leukaemia and Myeloma Research UK shared on X (Twitter): "We’re pleased to have awarded £57,500…

Nov 28, 2023, 22:45 | Blog

Doug R. Lowy: Good news from CDC Cancer

Doug R. Lowy, Acting Director of National Cancer Institute, made the following post on Twitter: "Good news…

Nov 22, 2023, 02:47 | Blog

Lucia Masarova: Let's tackle the inflammation in myelofibrosis! Era of combinational therapies is here

Lucia Masarova, Assistant Professor of the Department of Leukemia at MD Anderson Cancer Center, shared…

Nov 3, 2023, 12:29 | Insight

Talha Badar: In view of recent approval of IDH1i in MDS brief tweetorial

Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…

Oct 27, 2023, 17:01 | Drugs

Revumenib in relapsed or refractory KMT2Ar acute leukemia - Syndax Pharmaceuticals

Nicole McNeer, Senior Medical Director and Clinical Leader at Syndax Pharmaceuticals, shared a post by…

Oct 18, 2023, 21:48 | Blog

Yasmine Yasser: Excited to share that my thesis defense at the National Cancer Institute was a success!

Yasmine Yasser, Medical Oncology and Hematology Assistant Lecturer at the National Cancer Institute, Cairo University,…

Oct 1, 2023, 16:29 | Blog

Tracey O'Brien: At the Cancer Institute New South Wales (NSW), we’re proud to support incredible New South Wales researchers like Nunki Hassan.

Tracey O'Brien, New South Wales Chief Cancer Officer, shared a post by Cancer Institute New…

Sep 22, 2023, 11:56 | Positive

Dean Crowe: Grateful for these two!

Quoting Dean Crowe, Founder and CEO of Rally Foundation for Childhood Cancer Research, on LinkedIn:…

Sep 14, 2023, 17:52 | Career

Naveen Pemmaraju: Deeply honored to share that I have been Promoted to Professor of Leukemia!

Naveen Pemmaraju recently shared on X/Twitter: "Deeply honored to share that I have been Promoted…

Aug 31, 2023, 18:44 | Blog

Anand Patel: It was a pleasure speaking about accelerated/blast-phase MPNs at the Video Journal of Hematological Oncology IWAL meeting

Quoting Anand Patel, an Assistant Professor and the Director of Inpatient Leukemia Service at the…

Aug 31, 2023, 18:42 | Blog

Piers Blombery: Well done to Martin Vu for publishing this important health economic analysis on the cost-effectiveness of TP53/IGHV molecular testing in chronic lymphocytic leukemia in Australia.

Aug 20, 2023, 18:39 | Blog

Naveen Pemmaraju: Delighted to spend a few moments with Nobel Laureate Dr. Jim Allison at our Faculty Awards ceremony.

Quoting Naveen Pemmaraju, Assistant Professor in the Department of Leukemia at Anderson Cancer Center, stated…

Aug 20, 2023, 16:32 | Blog

Hagop Kantarjian: Join us in welcoming Alexandre Bazinet, MDCM, MSc to our MD Anderson Cancer Center Leukemia Faculty!

Hagop Kantarjian, Leukemia Professor and Chair at MD Anderson Cancer Center, shared on Twitter: "Join…

Aug 17, 2023, 16:33 | Blog

Amer Zeidan: It has been 16 years and 300 papers since my first paper was published in July 2007.

Amer Zeidan wrote in a recent tweet: ''It has been 16 years and 300 papers…

Aug 15, 2023, 08:33 | Positive

This is a story of resilience. Today, he stands as a symbol of hope - St. Baldrick's Foundation

Quoting from St. Baldrick's Foundation's LinkedIn: "This is a story of resilience. Shortly after a…

Aug 8, 2023, 18:54 | Blog

We have been able to bring novel state-of-the-art clinical trials to patients in the Tampa Bay region and beyond, many of which would not have access to trials otherwise - David Swoboda

Aug 5, 2023, 18:18 | Blog

MENA NCCN 2022-2023 guidelines have been published and posted on the NCCN website and the MNGHA website - Kanan Alshammari

We are happy to announce that the MENA NCCN 2022-2023 guidelines have been published and…

Aug 4, 2023, 16:16 | Positive

Every patient deserves access to quality cancer care - Gwen Nichols

Every patient deserves access to quality cancer care. Yet some groups of patients face more…

Jul 22, 2023, 17:56 | Drugs

High response rates in poor-risk population - Hagop Kantarjian

Our study of aza + ven + pevonedistat NEDD8-activating enzyme inhibitor in secondary AML &…

Jul 18, 2023, 19:39 | Drugs

Venetoclax helps to eliminate the adverse prognostic impact of splicing factor mutations in pts with newly diagnosed AML

Quoting Hagop Kantarjian on Twitter, "MD Anderson Cancer Center's Leukemia researchers identify the use of venetoclax…

Jul 12, 2023, 05:37 | Career

Leon Cristobal as the new Executive Director for LLS in the Greater Los Angeles Region!

While it's exciting to share my new role at The Leukemia & Lymphoma Society, it's…

Jul 9, 2023, 18:12 | Positive

NOTHING can make a doctor’s day brighter than sending their patient with leukemia , CANCER FREE home - Faheema Hasan

NOTHING can make a doctor’s day brighter than sending their patient with leukemia , CANCER…

Jul 8, 2023, 12:23 | Stories

Dr. Hagop Kantarjian isn’t just chair of Leukemia at MD Anderson - MD Anderson Cancer Center

Our Dr. Hagop Kantarjian isn’t just chair of Leukemia at MD Anderson; he’s also a…

Jul 7, 2023, 06:08 | Positive

28 years ago, in 1995, I was diagnosed with terminal leukemia - Mel Mann

28 years ago, in 1995, I was diagnosed with terminal leukemia and given 3 years…

Jul 6, 2023, 04:30 | Insight

A collection of clincally important insights in myeloma and MGUS - Vincent Rajkumar

1/ Serum protein electrophoresis may underestimate the true size of the M protein when the…

Jul 5, 2023, 05:38 | Blog

15 years ago exactly to the day, I arrived in Houston TX - Naveen Pemmaraju

So grateful to MD Anderson Cancer Center !! 15 years ago exactly to the day, I arrived…

Jul 3, 2023, 19:43 | Blog

Disparities in diagnosis and treatment for adult patients with acute leukemia - Gevorg Tamamyan

Our work presented at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting highlights the significant…

Jul 2, 2023, 16:48 | Dialogues

OncoInfluencers: Dialogue with Robert Peter Gale

OncoDaily is thrilled to launch a groundbreaking new series, "OncoInfluencers: Dialogues". This initiative aims to…

Jul 2, 2023, 07:46 | Drugs

LMICs struggle in the process of selecting potent drugs at suitable prices - Dr. Iyad Sultan

Italian hospitals have been treating children with cancer with Celginase, a drug unapproved in the…

Jul 1, 2023, 14:37 | Blog

Dr. Louis DeGennaro helped advance 70% of the 110 blood cancer treatments approved by the FDA in the last six years - The Leukemia & Lymphoma Society

As LLS President & CEO Dr. Louis DeGennaro officially retires on 7/1, we reflect on the incredible…

Jun 30, 2023, 18:19 | Positive

She’s a great example of what it means to survive and thrive - E. Anders Kolb

Throughout June, in commemoration of National Cancer Survivor Month, we at The Leukemia & Lymphoma Society have…

Jun 19, 2023, 18:50 | Blog

87.7% complete response in 28 days

In a post by Jan-Henning Klusmann on LinkedIn, it says, “Great news from our Department…

Jun 18, 2023, 16:33 | Opinion

My acute leukemia tip-sheet - Anand Patel

Anand Patel wrote on his Twitter account, "Sharing my acute leukemia tip-sheet for any interns…

Jun 16, 2023, 18:43 | Blog

This is a first in human clinical trial utilizing CD34+ selected allografts with gene-edited CD33neg hematopoietic stem cells from HLA matched related or unrelated donors for patients with AML - Guenther Koehne

Jun 2, 2023, 05:38 | Career

Florian Grebien Joins St. Anna CCRI as New Principal Investigator, Advancing Childhood Cancer Research

We are delighted to announce the appointment of Florian Grebien as the new Principal Investigator…

May 30, 2023, 17:47 | Positive

Samantha is now a PhD student exploring a potential therapeutic target in drug-resistant leukemia

"Samantha, driven by her personal experience with the devastating impact of cancer on families, has…

May 14, 2023, 09:40 | Positive

Legendary Dr. Hagop Kantarjian Receives Karnofsky Award for Transforming Care in Leukemia

Legendary Dr. Hagop Kantarjian Receives Karnofsky Award for Transforming Care in Leukemia Hagop Kantarjian, MD,…